Aurora Cannabis PE Ratio 2017-2023 | ACB
Current and historical p/e ratio for Aurora Cannabis (ACB) from 2017 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Aurora Cannabis PE ratio as of May 10, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Aurora Cannabis PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-05-13 | 6.68 | 0.00 | |
2023-12-31 | 4.76 | $-2.60 | 0.00 |
2023-09-30 | 5.85 | $-3.50 | 0.00 |
2023-06-30 | 5.35 | $-40.70 | 0.00 |
2022-12-31 | 9.23 | $-43.10 | 0.00 |
2022-09-30 | 12.20 | $-42.10 | 0.00 |
2022-03-31 | 40.00 | $-47.50 | 0.00 |
2021-12-31 | 54.10 | $-23.60 | 0.00 |
2021-09-30 | 69.20 | $-27.50 | 0.00 |
2021-03-31 | 93.10 | $-37.20 | 0.00 |
2020-12-31 | 83.10 | $-137.34 | 0.00 |
2020-09-30 | 46.50 | $-122.74 | 0.00 |
2020-03-31 | 108.71 | $-130.25 | 0.00 |
2019-12-31 | 259.20 | $-142.86 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.352B | $0.175B |
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $182.209B | 23.86 |
Stryker (SYK) | United States | $125.934B | 30.16 |
Medtronic (MDT) | Ireland | $109.997B | 15.57 |
Boston Scientific (BSX) | United States | $108.110B | 34.44 |
EssilorLuxottica (ESLOY) | France | $100.536B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.244B | 0.00 |
Haleon (HLN) | United Kingdom | $37.625B | 27.47 |
ResMed (RMD) | United States | $31.412B | 29.49 |
Terumo (TRUMY) | Japan | $25.118B | 35.47 |
Koninklijke Philips (PHG) | Netherlands | $24.962B | 19.34 |
Zimmer Biomet Holdings (ZBH) | United States | $24.957B | 15.94 |
Baxter (BAX) | United States | $18.187B | 12.93 |
Insulet (PODD) | United States | $11.617B | 51.52 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.025B | 0.00 |
Demant (WILYY) | Denmark | $10.234B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.042B | 26.31 |
BellRing Brands (BRBR) | United States | $7.836B | 36.71 |
Lantheus Holdings (LNTH) | United States | $5.269B | 13.13 |
Haemonetics (HAE) | United States | $4.868B | 24.08 |
GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
Perrigo (PRGO) | Ireland | $4.186B | 12.69 |
Prestige Consumer Healthcare (PBH) | United States | $3.495B | 16.52 |
Envista Holdings (NVST) | United States | $3.186B | 13.15 |
QuidelOrtho (QDEL) | United States | $2.854B | 15.84 |
Green Thumb Industries (GTBIF) | United States | $2.719B | 53.86 |
Neogen (NEOG) | United States | $2.671B | 25.69 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.630B | 0.00 |
ICU Medical (ICUI) | United States | $2.610B | 23.03 |
TG Therapeutics (TGTX) | United States | $2.569B | 72.26 |
Agios Pharmaceuticals (AGIO) | United States | $1.874B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.717B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.709B | 50.09 |
InMode (INMD) | Israel | $1.520B | 8.08 |
Warby Parker (WRBY) | United States | $1.466B | 0.00 |
Owens & Minor (OMI) | United States | $1.425B | 12.42 |
AdaptHealth (AHCO) | United States | $1.285B | 9.57 |
National Vision Holdings (EYE) | United States | $1.160B | 36.90 |
AtriCure (ATRC) | United States | $1.061B | 0.00 |
Canopy Growth (CGC) | Canada | $0.917B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.885B | 0.00 |
Evolus (EOLS) | United States | $0.798B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.726B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.711B | 15.13 |
Quanterix (QTRX) | United States | $0.638B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.628B | 14.77 |
PetIQ (PETQ) | United States | $0.543B | 17.73 |
Jin Medical (ZJYL) | China | $0.536B | 0.00 |
Valneva SE (VALN) | France | $0.517B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.487B | 0.00 |
Surmodics (SRDX) | United States | $0.459B | 28.71 |
Biote (BTMD) | United States | $0.456B | 8.74 |
ZimVie (ZIMV) | United States | $0.454B | 38.72 |
OraSure Technologies (OSUR) | United States | $0.359B | 11.57 |
Zynex (ZYXI) | United States | $0.333B | 45.61 |
Cerus (CERS) | United States | $0.320B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.277B | 27.48 |
Sanara MedTech (SMTI) | United States | $0.271B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 15.28 |
MacroGenics (MGNX) | United States | $0.207B | 0.00 |
Omeros (OMER) | United States | $0.203B | 0.00 |
Veru (VERU) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.182B | 0.00 |
High Tide (HITI) | Canada | $0.180B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.172B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.146B | 70.00 |
InterCure (INCR) | Israel | $0.145B | 24.54 |
FitLife Brands (FTLF) | United States | $0.138B | 22.22 |
Jushi Holdings (JUSHF) | United States | $0.136B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.110B | 0.00 |
Fonar (FONR) | United States | $0.107B | 9.17 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.087B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
Safety Shot (SHOT) | United States | $0.059B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.85 |
Apyx Medical (APYX) | United States | $0.052B | 0.00 |
Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
ImmuCell (ICCC) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.039B | 14.08 |
Modular Medical (MODD) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
GlucoTrack (GCTK) | United States | $0.015B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 74.77 |
IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |